Bcm-95 Curcumin — Why Bioavailability Is Everything
Quick Read Standard curcumin supplements are poorly absorbed by your body because curcumin doesn’t dissolve well in water and is
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
NAD+ is a molecule inside your cells that powers energy production and repairs DNA, but levels drop roughly in half by your 50s compared to your 20s. NMN is a supplement that your body converts into NAD+. Multiple clinical trials confirm that NMN reliably raises blood NAD+ levels at doses between 250 mg and 900 mg daily, and appears safe with no serious side effects reported.
The functional benefits show promising but inconsistent results. Several independent trials found improvements in walking speed, lower limb strength, and sleep quality, particularly when NMN was taken in the afternoon. However, these studies used small sample sizes and effects were moderate, not dramatic. The most striking anti-aging results come from mouse studies, but translating those findings to humans remains uncertain.
If you are in your 40s, 50s or 60s and concerned about energy decline or physical performance, NMN is a reasonable option given its safety profile and emerging evidence of benefit. A sensible starting dose is 250 to 300 mg daily, taken for at least 12 weeks to see effects. However, NMN should complement rather than replace sleep, exercise, good nutrition and stress management.
Verdict: NMN safely raises NAD+ levels and shows encouraging early-stage signals for energy and physical function in older adults, but human evidence remains promising rather than definitive and requires longer, larger trials before claiming proven anti-aging benefits.
There’s a molecule sitting inside every cell in your body right now, quietly powering almost everything that keeps you alive, from the way your muscles contract to how your brain files memories. It’s called NAD⁺. And here’s the uncomfortable truth that a growing body of research is beginning to confirm: by the time you reach your 50s, you may have roughly half the NAD⁺ you had in your 20s [8]. Not because something has gone wrong. Simply because that’s what ageing does.
Now, what if you could meaningfully slow that decline, or even partially reverse it? That’s the question driving one of the most actively researched areas in longevity science right now, and it’s why a compound called nicotinamide mononucleotide, NMN, has moved from obscure biochemistry journals into serious clinical conversation. We’ve reviewed 15 research papers from the Vitacuity database, drawn from the 1.77 million studies our team has analysed, to give you an honest picture of what the evidence actually shows. No hype. No cherry-picking. Just what we know, what we don’t, and what a sensible person might actually do with this information.
To understand NMN, you first need to understand what NAD⁺ does, and why its decline matters so much.
NAD⁺ (nicotinamide adenine dinucleotide) is sometimes called the “master regulator” of cellular energy. It’s a coenzyme, a helper molecule, that sits at the heart of how your cells generate usable energy from the food you eat. Your mitochondria, the tiny power stations inside each cell, depend on NAD⁺ to do their job. Without adequate NAD⁺, this energy conversion process becomes less efficient [3].
But NAD⁺ does more than make energy. It also activates a family of proteins called sirtuins, which regulate DNA repair, inflammation control and stress responses. It fuels PARP enzymes, which patch up damaged DNA. And it plays a central role in maintaining what researchers call “mitochondrial homeostasis”, keeping your cellular power plants running cleanly rather than leaking damaging free radicals [8] [13].
Here’s the problem: NAD⁺ levels decline with age. The mechanisms aren’t fully understood, but current thinking suggests it’s a combination of reduced production and increased consumption, as your body faces more oxidative stress and DNA damage with age, it burns through more NAD⁺ trying to manage the damage [5] [8]. This creates a frustrating cycle: the older you get, the more you need it, and the less you have.
NMN, nicotinamide mononucleotide, is a direct precursor to NAD⁺. Think of it as the raw material your cells use to make NAD⁺. When you take NMN orally, your body absorbs it and converts it into NAD⁺ within tissues [6] [13]. The idea, then, is simple: give your cells more of the building blocks they need, and they’ll make more NAD⁺. The question is whether this biochemical logic translates into real, felt benefits in humans. That’s where the evidence gets genuinely interesting, and genuinely complicated.
Evidence grade: Strong for the biomarker; Promising for what it means clinically
Across multiple randomised controlled trials, one finding appears consistently: oral NMN supplementation reliably raises NAD⁺ levels in the blood. This is not in doubt.
A 2022 placebo-controlled, randomised, double-blind trial published in *Frontiers in Nutrition* gave 15 healthy subjects 250 mg of NMN daily for 12 weeks. NAD⁺ levels in whole blood increased significantly compared to placebo, with no adverse effects or abnormal laboratory findings observed [13].
A 2023 multicentre randomised controlled trial published in *GeroScience*, one of the more rigorously designed studies in this field, enrolled 80 healthy middle-aged adults across doses of 300 mg, 600 mg and 900 mg NMN per day for 60 days. Blood NAD⁺ concentrations increased significantly in all three NMN groups compared to both placebo and baseline at days 30 and 60 (all p ≤ 0.001). The 600 mg and 900 mg groups showed the highest NAD⁺ levels [12].
A 2022 Japanese trial published in *NPJ Aging and Mechanisms of Disease* gave 250 mg NMN daily to healthy older men for 6 or 12 weeks in a randomised, double-blind, placebo-controlled design, and confirmed that metabolomic analysis of whole blood showed significantly increased NAD⁺ and NAD⁺ metabolite concentrations [11].
The 2026 PRISMA-guided systematic review, examining 33 human intervention studies, concluded that oral NMN “consistently demonstrated biochemical target engagement” in terms of raising circulating NAD⁺ levels [1]. The 2026 meta-analysis of 15 randomised controlled trials similarly confirmed this pattern, with NMN doses ranging from 250 mg to 2,000 mg per day across durations of two weeks to six months [2].
So if you’re taking NMN and wondering whether it’s doing *something* at a biochemical level, the evidence says yes, it almost certainly is. The more nuanced question is what that elevated NAD⁺ actually translates to in terms of how you feel and function. And that’s where the research gets more textured.
Evidence grade: Promising, some consistent human trial findings, but sample sizes are small and effect sizes moderate
The 2023 *GeroScience* trial that found rising NAD⁺ levels also measured physical performance using the six-minute walking test. Walking distance increased significantly in all three NMN groups (300 mg, 600 mg and 900 mg) compared to placebo at both days 30 and 60 (all p < 0.01), with the greatest improvements in the 600 mg and 900 mg groups. This is an 80-person trial, so meaningful, but not yet definitive [12].
The 2024 study published in *GeroScience*, which followed 60 older adults over 12 weeks using 250 mg NMN daily, found that at 12 weeks, the NMN group had a significantly shorter 4-metre walking time than the placebo group. Crucially, the researchers also found a significant negative correlation between the improvement in walking time and the increase in blood NAD⁺ levels, suggesting the mechanism of action is plausibly what we think it is [15].
The 2022 Japanese randomised controlled trial in *Nutrients*, which followed 108 older adults taking 250 mg NMN (morning or afternoon) or placebo for 12 weeks, found that the NMN afternoon group demonstrated the largest effect size for five-times sit-to-stand performance (Cohen’s d = 0.72), a measure of lower limb strength and functional mobility [7].
A 2024 systematic review in *Cureus* pooled data from 10 randomised controlled trials covering 437 patients with a mean age of 58 years. NMN doses ranged from 150 mg to 1,200 mg per day. The review found non-significantly improved grip strength and skeletal mass index in NMN groups, describing these as positive trends that didn’t reach statistical significance, likely because the individual studies were too small and too short to power these outcomes properly [10].
Taken together: the physical performance signals are real and directionally consistent, but we’re not yet at the level of evidence where we can say definitively “NMN will make you measurably stronger.” What we can say is that the trend is in the right direction across multiple independent studies, and the mechanism, more NAD⁺ supporting better mitochondrial function in muscle, is biologically plausible [6] [8].
Evidence grade: Promising, single RCT, needs replication
One of the more practically interesting findings in this literature is about *when* you take NMN, not just whether you take it.
The 2022 Japanese randomised controlled trial in *Nutrients*, studying 108 older adults over 12 weeks, found that the group taking NMN in the afternoon showed the greatest improvement in drowsiness scores (Cohen’s d = 0.64) compared to placebo and to the morning NMN group. The reduction in daytime drowsiness was a secondary endpoint, and the researchers suggest this timing effect may relate to NAD⁺’s role in circadian rhythm regulation [7].
The 2024 double-blind, placebo-controlled study of 60 older adults taking 250 mg NMN daily for 12 weeks also found improved sleep quality, specifically, significantly lower scores for “daytime dysfunction” and overall sleep quality on the Pittsburgh Sleep Quality Index at 12 weeks [15].
This is interesting because energy and fatigue are not just about how much power your cells can generate, they’re also about how well you sleep and how regulated your body clock is. NAD⁺ is involved in the molecular machinery that drives your circadian rhythm, which may partly explain why these sleep and alertness effects appear in the data [7] [15].
To be clear: these are promising signals, not proven outcomes. Both studies are relatively small, and the effects, while statistically significant, were measured over short periods. But they’re interesting enough to be worth taking seriously, particularly if fatigue and poor sleep are among your chief concerns.
Evidence grade: Early stage for longevity outcomes, animal studies, human translation unclear
Much of the excitement about NMN originated in preclinical research, and it’s worth understanding what those studies actually showed, and where their limits lie.
The landmark 2016 study from Washington University School of Medicine, published in *Cell Metabolism*, administered NMN to aging mice for 12 months. The results were striking: NMN suppressed age-associated body weight gain, enhanced energy metabolism, promoted physical activity, improved insulin sensitivity and plasma lipid profiles, and even ameliorated eye function. The researchers also found that NMN prevented age-associated gene expression changes in metabolic organs and enhanced mitochondrial oxidative metabolism in skeletal muscle [6].
This study is frequently cited as the foundational evidence for NMN’s anti-ageing potential, and rightly so. Twelve months of supplementation in mice with no observed toxicity, and a broad suite of beneficial metabolic effects, is genuinely encouraging [6].
The catch, and it’s an important one, is that mice are not people. A 2025 review in *Nature Metabolism* noted plainly that “the extrapolation of rodent-based data is not straightforward” and that human data on tissue-specific NAD⁺ changes and supplementation effects remain sparse [5]. The 2026 systematic review across 113 studies similarly concluded that while rodent data is frequently positive, human outcomes have been “heterogeneous and often null or endpoint-specific” [1].
This doesn’t mean the mouse data is irrelevant, it tells us the biological machinery exists and can respond to NMN. But it does mean we should temper our expectations when translating those dramatic mouse results to a human supplement routine.
Evidence grade: Strong for short-term safety
Whatever questions remain about NMN’s functional benefits, the safety data is reassuringly consistent.
The 2026 meta-analysis covering 15 randomised controlled trials and doses from 250 mg to 2,000 mg per day found that NMN did not increase overall adverse events, serious adverse events, withdrawal-related events or system-specific adverse events. Liver enzymes (ALT and AST) were not significantly elevated [2].
The 2023 multicentre trial found that 900 mg daily for 60 days was well tolerated with no safety issues [12]. The 2022 Japanese trial found no significant deleterious effects at 250 mg daily over 12 weeks [11]. The 2022 *Frontiers in Nutrition* trial found no abnormalities in physiological or laboratory tests at 250 mg for 12 weeks [13]. The 2024 systematic review of 437 patients across 10 trials found no serious adverse effects [10].
The 2026 systematic review of 33 human intervention studies confirmed that NMN is “generally well tolerated over weeks to months” [1].
The safety window here, at the doses commonly used in supplements (250 mg to 600 mg daily), looks genuinely solid based on current evidence. Long-term safety data (beyond six months) in humans is still limited, but everything we have so far is reassuring.
Evidence grade: Promising, single RCT, novel measurement tool
The 2023 *GeroScience* trial included an unusual secondary measure: biological age calculated using the Aging.Ai 3.0 calculator, which uses standard blood biomarkers to estimate biological rather than chronological age. The result? Blood biological age increased significantly in the placebo group over 60 days, as you might expect, normal ageing doesn’t pause, but stayed unchanged in all three NMN-treated groups. This difference reached statistical significance (all p < 0.05) [12].
This is a genuinely interesting finding, but it needs heavy qualification. The Aging.Ai calculator is a computational tool, not a gold-standard clinical measure of ageing. The study was 60 days long and included only 80 participants. What it suggests is that NMN may be exerting some protective effect on blood-based biomarkers of ageing, but we are very far from being able to conclude that NMN “slows ageing” in any meaningful clinical sense.
On metabolic markers, blood sugar, cholesterol, insulin resistance (HOMA-IR), body weight, the picture is largely neutral in human trials. The 2026 meta-analysis found no significant effects on fasting glucose, HbA1c, lipid profiles or body weight [2]. The 2023 trial found no significant difference in HOMA-IR between NMN and placebo groups [12]. A slight decrease in diastolic blood pressure appeared in the meta-analysis, and HOMA-IR showed a “non-significant downward trend”, flagged as “preliminary vascular-metabolic signals, especially in older adults or people with early metabolic risk” [2].
This is the section that doesn’t get written often enough in supplement content, and it matters.
We don’t know the optimal dose. Human trials have used everything from 150 mg to 2,000 mg daily. The 2023 multicentre trial suggests 600 mg may be a sweet spot for NAD⁺ elevation and physical performance [12], but this hasn’t been confirmed across multiple independent studies. The 2026 review notes that NAD⁺ responses are “nonlinear” and influenced by dose, age, metabolic state and individual variation, not a simple more-is-better relationship [3].
We don’t know if raising blood NAD⁺ translates to raising NAD⁺ in the tissues that matter most. Blood levels are a proxy. The 2025 *Nature Metabolism* review was explicit that “the published body of data on NAD⁺ dynamics in human tissues remains sparse” [5]. Muscle, brain and liver may respond differently, and the mechanisms of how NMN crosses into different tissues in humans are still being mapped.
We don’t have long-term human data. The longest human trials in this dataset run to 24 weeks [2]. We have no data on what happens with years of supplementation in humans, though the 12-month mouse study was reassuring in terms of safety [6].
The functional benefits remain inconsistent across studies. The 2026 PRISMA systematic review was clear: while NAD⁺ is reliably raised, “effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were heterogeneous and often null or endpoint-specific” [1]. Not every trial found significant improvements in physical performance, energy or sleep, the positive findings are real but not universal.
We don’t know how much individual NAD⁺ baseline levels matter. Someone who is severely NAD⁺ deficient might respond very differently to supplementation than someone whose levels are already relatively intact. The 2022 trial noted that the increase in NAD⁺ after supplementation correlated with baseline pulse rate, hinting that individual physiological state influences response [13].
Most of the impressive anti-ageing data is still in mice. As the 2025 *Nature Metabolism* review cautioned, human translation of rodent findings is not straightforward [5]. The mouse studies are mechanistically important but should not be taken as proof of equivalent effects in people.
Let’s reason through this like a sensible, well-informed friend rather than a cautious academic hedging every sentence.
Here’s what we can say with confidence: NMN is safe at doses of 250 mg to 900 mg per day based on all available human trial data [1] [2] [10]. It reliably raises NAD⁺ in the blood [1] [12] [13]. There are consistent, directionally positive signals across multiple independent trials for physical performance, walking speed, lower limb function and sleep quality [7] [11] [12] [15]. The mechanism is biologically coherent, more NAD⁺ means better mitochondrial function, better cellular energy metabolism, better DNA repair [3] [6] [8].
Here’s what we cannot say: that NMN is proven to restore youthful energy, reverse ageing, or deliver the dramatic results seen in the mouse studies [1] [5]. The human evidence is promising but not yet definitive for functional outcomes. Effect sizes are moderate. Sample sizes in individual trials are small. We need longer, larger trials.
So what would a sensible, informed person actually do?
If you’re in your 40s, 50s or 60s, concerned about energy decline, physical performance and sleep quality, and you’re looking for a safe, evidence-backed intervention: NMN is a reasonable consideration. The safety profile is strong. The biological rationale is sound. The early clinical signals on energy, fatigue and physical function are encouraging enough to take seriously, particularly given that doing nothing about NAD⁺ decline carries its own risks [5] [8].
On dose: the multicentre RCT data suggests 300 mg may be a sensible starting point, with 600 mg associated with the strongest physical performance outcomes in one well-designed trial [12]. Most trials have used 250 mg with positive results [7] [11] [13] [15]. Start at 250–300 mg and consider 600 mg if you’re specifically targeting physical performance or energy restoration.
On timing: one randomised controlled trial found afternoon supplementation produced the largest effect sizes for lower limb function and drowsiness reduction [7]. This is a single study and needs replication, but it’s a low-cost, low-effort adjustment worth considering.
On expectations: give it at least 12 weeks. Most of the positive human findings emerged at or after the 12-week mark [11] [12] [13] [15]. NAD⁺ metabolism is not something you’ll feel dramatically overnight.
On testing: unlike some nutrients, there’s no widely available, affordable NAD⁺ blood test for routine consumer use. But unlike iron, where supplementing without deficiency can cause harm, NMN at normal doses is safe for healthy adults without prior testing [2] [10]. The risk-benefit calculation here favours supplementation without requiring a clinic visit first.
Finally: NMN is not a replacement for sleep, movement, good nutrition or stress management. Those remain the foundations. But if you’re already doing the basics and want to support cellular energy metabolism as you age, the evidence, while not yet definitive, is interesting enough to make this one worth taking seriously.
[1] NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence (2026). DOI: https://doi.org/10.1016/j.arr.2026.103057 | PubMed: https://pubmed.ncbi.nlm.nih.gov/41655607/
[2] Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis (2026). DOI: https://doi.org/10.3390/nu18142251 | PubMed: https://pubmed.ncbi.nlm.nih.gov/42514320/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13414721/
[3] NAD⁺ biology and supplementation: From mechanisms to clinical perspectives (2026). DOI: https://doi.org/10.1007/s11033-026-12351-3 | PubMed: https://pubmed.ncbi.nlm.nih.gov/42489969/
[4] Restorin® NR is a Highly Efficient NAD+ Precursor (2026). DOI: https://doi.org/10.2147/DDDT.S639156 | PubMed: https://pubmed.ncbi.nlm.nih.gov/42582917/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13458679/
[5] NAD+ precursor supplementation in human ageing: clinical evidence and challenges (2025). DOI: https://doi.org/10.1038/s42255-025-01387-7 | PubMed: https://pubmed.ncbi.nlm.nih.gov/41083806/
[6] Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice (2016). DOI: https://doi.org/10.1016/j.cmet.2016.09.013 | PubMed: https://pubmed.ncbi.nlm.nih.gov/28068222/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668137/
[7] Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study (2022). DOI: https://doi.org/10.3390/nu14040755 | PubMed: https://pubmed.ncbi.nlm.nih.gov/35215405/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877443/
[8] Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing (2021). DOI: https://doi.org/10.1016/j.mad.2021.111567 | PubMed: https://pubmed.ncbi.nlm.nih.gov/34517020/
[9] Research progress on anti-aging effects of β-nicotinamide mononucleotide (NMN) (2024). PubMed: https://pubmed.ncbi.nlm.nih.gov/39780578/
[10] Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials (2024). DOI: https://doi.org/10.7759/cureus.65961 | PubMed: https://pubmed.ncbi.nlm.nih.gov/39221308/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11365583/
[11] Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men (2022). PubMed: https://pubmed.ncbi.nlm.nih.gov/35927255/
[12] The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023). DOI: https://doi.org/10.1007/s11357-022-00705-1 | PubMed: https://pubmed.ncbi.nlm.nih.gov/36482258/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735188/
[13] Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects (2022). DOI: https://doi.org/10.3389/fnut.2022.868640 | PubMed: https://pubmed.ncbi.nlm.nih.gov/35479740/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036060/
[14] The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update (2023). DOI: https://doi.org/10.1016/j.advnut.2023.08.008 | PubMed: https://pubmed.ncbi.nlm.nih.gov/37619764/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721522/
[15] Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study (2024). DOI: https://doi.org/10.1007/s11357-024-01204-1 | PubMed: https://pubmed.ncbi.nlm.nih.gov/38789831/ | PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336149/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Standard curcumin supplements are poorly absorbed by your body because curcumin doesn’t dissolve well in water and is
Quick Read Your gut bacteria and brain communicate through a direct pathway. When you eat prebiotic fibre, your gut bacteria
The nutrients that matter, the forms that work, and the claims to ignore.
